MAFB and hepatocellular carcinoma: However, HCC patients with lower MAFB and higher MAFF expression (median DFS time: 11.5 months) showed poorer DFS than those with higher expression of both MAFB and MAFF (35.8 months, p = 0.003) and those with lower expression of both MAFB and MAFF (25.3 months, p = 0.017) (see Figure 8B,D and Figure S8B).